Skip to main content
. Author manuscript; available in PMC: 2021 Nov 15.
Published in final edited form as: Cancer. 2020 Sep 21;126(22):4957–4966. doi: 10.1002/cncr.33121

Table 2.

Frequency of delayed treatment initiation and prolonged treatment duration by race, age, and latent classes of SES and access to care in Carolina Breast Cancer Study 3 (2008-2013)

Treatment initiation Treatment durationa

≤60 days >60 days Q1-3 Q4


No. (%) No. (%) No. (%) No. (%)
Raceb
   White 1333 (92.1) 115 (7.9) 1143 (78.9) 305 (21.1)
   Black 1206 (86.6) 187 (13.4) 976 (70.1) 417 (29.9)
   Black vs. white, RFD (95% CI) ref 5.5% (3.2, 7.8) ref 8.8% (5.7, 12.0)
Agec
   Older 1272 (89.3) 153 (10.7) 1086 (76.2) 339 (23.8)
   Younger 1267 (89.5) 149 (10.5) 1033 (73.0) 383 (27.0)
   Younger vs. older, RFD (95% CI) ref 0.3% (−1.9, 2.5) ref 3.2% (0.1, 6.3)
SES latent classesd
   High SES 1378 (91.6) 127 (8.4) 1192 (79.2) 313 (20.8)
   Low SES 1161 (86.9) 175 (13.1) 927 (69.4) 409 (30.6)
   Low vs. High, RFD (95% CI) ref 3.5% (1.2, 5.9) ref 8.1% (4.7, 11.5)
Access to care latent classesd
   Fewer Barriers to Care 2311 (89.8) 264 (10.2) 1954 (75.9) 621 (24.1)
   More Barriers to Care 227 (85.7) 38 (14.3) 164 (61.9) 101 (38.1)
   Low vs. high, RFD (95% CI) ref 2.8% (−1.6, 7.2) ref 11.7% (5.5, 17.8)
a

Quartiles were separately defined by modality and Q4 was equal to 56, 74, 119 days for radiation, definitive surgery, and chemotherapy modalities, respectively

b

Multivariate models adjusting for age

c

Multivariate models adjusting for race

d

Multivariate models adjusting for race and age

Abbreviations: CI, confidence interval; RFD, relative frequency difference; SES, socioeconomic status